Simon Völkl
Impact in
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 1%
- T-cell and B-cell Immunology
- Immune cells in cancer
Papers in
- Immunology 32
- T-cell and B-cell Immunology 16
- Immune cells in cancer 7
- Immunotherapy and Immune Responses 7
- Oncology 33
- CAR-T cell therapy research 30
- Co-authors
- Andréas Mackensen (58 shared papers)Reinhard Andreesen (5 shared papers)Leoni A. Kunz‐Schughart (4 shared papers)Michael Aigner (28 shared papers)Dimitrios Mougiakakos (23 shared papers)Marina P Kreutz (4 shared papers)Eva Gottfried (2 shared papers)Matthias Edinger (2 shared papers)
- Journals
- Blood (10 papers)Nature Medicine (4 papers)Journal for ImmunoTherapy of Cancer (4 papers)Frontiers in Immunology (4 papers)The Lancet (3 papers)
- Partner nations
- GermanyItalyUnited States
In The Last Decade
Simon Völkl
94 papers receiving 6.8k citations
Simon Völkl's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 2.5k
- Immunology 1.6k
- Cancer Research 804
- Rheumatology 758
- Hematology 323
Countries citing papers authored by Simon Völkl
This map shows the geographic impact of Simon Völkl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Völkl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Völkl more than expected).
Fields of papers citing papers by Simon Völkl
This network shows the impact of papers produced by Simon Völkl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Völkl. The network helps show where Simon Völkl may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Völkl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibitory effect of tumor cell–derived lactic acid on human T cells Hit paper breakdown → | 2007 | 1620 |
| 2 | Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus Hit paper breakdown → | 2022 | 777 |
| 3 | CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up Hit paper breakdown → | 2024 | 682 |
| 4 | CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus Hit paper breakdown → | 2021 | 443 |
| 5 | 2020 | 382 | |
| 6 | 2004 | 228 | |
| 7 | CD19-targeted CAR T cells in refractory antisynthetase syndrome Hit paper breakdown → | 2023 | 206 |
| 8 | Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells Hit paper breakdown → | 2023 | 170 |
| 9 | 2006 | 144 | |
| 10 | 2011 | 91 | |
| 11 | 2021 | 90 | |
| 12 | CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis Hit paper breakdown → | 2024 | 82 |
| 13 | 2018 | 78 | |
| 14 | 2023 | 76 | |
| 15 | 2016 | 75 | |
| 16 | CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series Hit paper breakdown → | 2024 | 74 |
| 17 | 2021 | 73 | |
| 18 | 2013 | 70 | |
| 19 | Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study Hit paper breakdown → | 2025 | 61 |
| 20 | 2016 | 56 |
About Simon Völkl
Simon Völkl is a scholar working on Immunology, Oncology, Hematology, Rheumatology and Cancer Research, having authored 101 papers that have together received 6.9k indexed citations. Recurring topics across this work include CAR-T cell therapy research (30 papers), T-cell and B-cell Immunology (16 papers), Hematopoietic Stem Cell Transplantation (9 papers), Systemic Lupus Erythematosus Research (9 papers), Immune cells in cancer (7 papers), Immunotherapy and Immune Responses (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Blood transfusion and management (4 papers). The work is most often cited by research in Oncology (2.5k citations), Immunology (1.6k citations), Cancer Research (804 citations), Rheumatology (758 citations) and Hematology (323 citations). Simon Völkl has collaborated with scholars based in Germany, Italy and United States. Frequent co-authors include Andréas Mackensen, Reinhard Andreesen, Leoni A. Kunz‐Schughart, Michael Aigner, Dimitrios Mougiakakos, Marina P Kreutz, Eva Gottfried, Matthias Edinger, Petra Hoffmann and Sabine Hoves. Their work appears in journals such as Blood, Nature Medicine, Journal for ImmunoTherapy of Cancer, Frontiers in Immunology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.